Clinical Trial Update: A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears [NA]

View source ↗

Summary

Clinical trial update for a multi-center safety study of autologous adipose-derived regenerative cell injections in chronic partial-thickness rotator cuff tears…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-thickness Rotator Cuff Tear

Drugs mentioned

• Autologous Adipose-Derived Regenerative Cell Injection (adipose-derived regenerative cells)

Snippet

Sponsor: InGeneron, Inc. | Conditions: Partial Thickness Rotator Cuff Tear | NA | Status: ENROLLING_BY_INVITATION